Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Trade private companies

Browse Biotech & Pharma Companies

Biotech focuses on infusing biological processes with technology to improve human, animal, and environmental health. Biotech & Pharma businesses utilize technology to work toward disease prevention, treatment and cure. These businesses also work in Agtech and fuel development. Register today to discover how Forge can help you buy and sell private shares.

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Less than $500MM
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Filters (3)
More (3)
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Less than $500MM
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Reset
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
CinCor PharmaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$192.86MMSeries B10/12/2021$142.86MM$370.57MM$4.00General Atlantic, Perceptive Advisors, BVF Partners, venBio Partners, Adage Capital Management, Omega Funds, Rock Springs Capital, RTW Investments, Lilly Asia Ventures, Sixty Degree Capital, Sofinnova Investments, Sofinnova Partners, 5AM Ventures, CinRx
UnlearnHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$135.17MMSeries C2/8/2024$50MM$368.17MM$9.24Altimeter Capital Management, Radical Ventures, Mubadala Capital, Wittington Ventures, EPIC Ventures, Necessary Ventures, Insight Partners, 8VC, DCVC
Tetherex PharmaceuticalsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$68.65MMSeries B4/18/2018$63.95MM$366.68MM$21.32MPM Capital, Philip Jones
Ampersand BiomedicinesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$109.61MMSeries B3/19/2025$65MM$360.94MM$5.80Flagship Pioneering, Eli Lilly & Company
Alterome TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$231.07MMSeries B4/3/2024$132MM$356.19MM$4.08Goldman Sachs Alternatives, Canaan Partners, Invus, Driehaus Capital Management, Digitalis Ventures, Blue Owl Capital, OrbiMed, Nextech Invest, Vida Ventures, Boxer Capital, Colt Ventures
Capstan MedicalHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$152.91MMSeries C12/11/2024$110MM$355.75MM$14.43Eclipse, Intuitive Ventures, Yu Galaxy, Gideon Strategic Partners
Tune TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$223.37MMSeries B-11/13/2025$61.49MM$355.58MM$1.20New Enterprise Associates, Yosemite, Regeneron Ventures, Hevolution Foundation
Ashvattha TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$123.69MMSeries B1/13/2025$119MM$353.38MM$8.37Huadong Medicine, Natural Capital, Plum Alley, Tribe Capital
BioTheryXHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$173.09MMSeries E5/20/2021$100MM$348.42MM$5.25Farallon Capital Management, Avidity Partners, Deep Track Capital, Irving Investors, Janus Henderson Investors, Lumira Ventures, Point72, Rock Springs Capital, Surveyor Capital, Tekla Capital management, Alexandria Ventur Investors, Wedbush Helthcare Partners
Tyra BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$157.64MMSeries B3/31/2021$106.3MM$348.37MM$27.43Nextech Invest, Cormorant Asset Management, BVF Partners, Janus Henderson Investors, Logos, Alta Partners, RA Capital, Boxer Capital, Cannaan
IsoPlexisHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$161.52MMSeries D1/7/2021$92.5MM$348.21MM$76.92Perceptive Advisors, Ally Bridge Group, BlackRock
EvommuneHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$268.46MMSeries C10/31/2024$115.5MM$346.35MM$1.59RA Capital Management, Sectoral Asset Management, B Capital, Marshall Wace, Avego Bioscience Capital, Longwood Fund, RTW Investments, ADAR1 Capital Management, NEXTBio Capital, Beiersdorf Venture Capital, FemHealth Ventures, Allostery Investments LP, Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners, Amplitude Ventures, SymBiosis, Verition Fund Management
ApexigenHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$165.38MMSeries C3/24/2020$127.86MM$343.82MM$1.55Decheng Capital, Oceanpine Capital, 3E Bioventures Capital, VI Ventures, SV Tech Ventures, H&Q Asia Pacific, LDV Ventures, ShangBay Capital, Delian Capital, Hua Nan Venture Capital, Efung Capital
Aspen NeuroscienceHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$339.74MMSeries C11/20/2025$115.62MM$339.66MM$1.52OrbiMed, ARCH Venture Partners, Frazier Healthcare Partners, Revelation Partners, Medical Excellence Capital, S32, Axon Ventures, LYFE Capital, LifeForce Capital, Kite, Balyasny Asset Management, Cormorant Asset Management, Prebys Ventures
Hexagon BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$194.66MMSeries B2/13/2023$77.3MM$338.5MM$4.23The Column Group, Two Sigma Ventures, 8VC, Nextech Invest, CPP Investments, ATEL Ventures
AgNovos BioscienceHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$257.83MMSeries B12/20/2023$44.85MM$338.24MM$35.76Undisclosed Investors
Emerald Cloud LabHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$151.12MMNew Series C-17/25/2025$65MM$335.94MM$0.51Undisclosed Investors
Vanqua BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$149.15MMSeries B7/12/2024$130MM$333.4MM$4.06Omega Funds, OrbiMed, Citadel, Avoro Ventures, Casdin Capital, Pontifax, Eli Lilly and Company, Logos Capital, Osage University Partners
ShapeTXHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$249.61MMSeries C-11/7/2025$91.03MM$333.34MM$0.41Undisclosed Investors
EgenesisHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$1.4BSeries D9/4/2024$90.96MM$332.59MM$0.20Lux Capital, ARCH Venture Partners, Khosla Ventures, Farallon Capital Management, Alta Partners, Fresenius Medical Care Ventures, Leaps by Bayer, DaVita, Eisai Innovation, NATCO Pharmaceuticals, Parkwood Corporation
Neuron23Healthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$310.11MMSeries D6/24/2025$96.5MM$331.2MM$0.99Westlake Village BioPartners, SoftBank, Redmile Group, Blue Owl, Kleiner Perkins, HBM Healthcare Investments, Acorn Bioventures
ClevelandDxHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$117.45MMSeries E-210/7/2025$26.99MM$330.17MM$4.99Novo Holdings
Recludix PharmaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$123.5MMSeries B1/12/2026$21.5MM$327.7MM$2.31Access Biotechnology, Alexandria Venture Investments, NEA, Westlake Village BioPartners, Eli Lilly
TheracosHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$135.86MMSeries C9/20/2013$93.09MM$327.39MM$18.62Undisclosed Investors
49-72 of 170

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.